Sling Therapeutics to Announce Topline Results from Phase 2b/3 LIDS Clinical Trial of Oral Small Molecule Linsitinib in Patients with Thyroid Eye Disease at the 43rd Annual J.P. Morgan Healthcare Conference

Sling Therapeutics to Announce Topline Results from Phase 2b/3 LIDS Clinical Trial of Oral Small Molecule Linsitinib in Patients with Thyroid Eye Disease at the 43rd Annual J.P. Morgan Healthcare Conference

ANN ARBOR, Mich., Jan. 13, 2025 /PRNewswire/ — Sling Therapeutics, Inc., a late-stage biopharmaceutical company focused…

Continue Reading
Healthcare dealmakers eye M&A resurgence in second Trump term

Healthcare dealmakers eye M&A resurgence in second Trump term

By Sabrina Valle NEW YORK (Reuters) -Healthcare dealmakers gathering in San Francisco for the industry’s premier…

Continue Reading
Director’s role ‘changing the face of healthcare’

Director’s role ‘changing the face of healthcare’

He’ll also take cues from the Patient Experience Committee and Patient Partners in the Niagara Health…

Continue Reading
Healthcare Industry Shaken As Private Equity Reportedly Eyes Walgreens Acquisition

Healthcare Industry Shaken As Private Equity Reportedly Eyes Walgreens Acquisition

In a development that could reshape the U.S. healthcare landscape, Walgreens Boots Alliance (NASDAQ: WBA) is…

Continue Reading
Researchers Exploring Ways To Transform Healthcare With Brain Technology

Researchers Exploring Ways To Transform Healthcare With Brain Technology

Researchers at York University are looking into ways to improve healthcare with brain technology. One of…

Continue Reading
VISTA Eye Specialist Redefines Healthcare Marketing in Malaysia with Groundbreaking “31 Days Challenge” Campaign | Taiwan News

VISTA Eye Specialist Redefines Healthcare Marketing in Malaysia with Groundbreaking “31 Days Challenge” Campaign | Taiwan News

PETALING JAYA, Malaysia, Dec. 20, 2024 /PRNewswire/ — Leading the way in advanced eye care and…

Continue Reading